Cargando…
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer
Background: In order to characterize the various subtypes of breast cancer more precisely and improve patients selection for breast conserving therapy (BCT), molecular profiling has gained importance over the past two decades. MicroRNAs, which are small non-coding RNAs, can potentially regulate nume...
Autores principales: | Zellinger, Barbara, Bodenhofer, Ulrich, Engländer, Immanuela A., Kronberger, Cornelia, Strasser, Peter, Grambozov, Brane, Fastner, Gerd, Stana, Markus, Reitsamer, Roland, Sotlar, Karl, Sedlmayer, Felix, Zehentmayr, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759924/ https://www.ncbi.nlm.nih.gov/pubmed/33255991 http://dx.doi.org/10.3390/genes11121404 |
Ejemplares similares
-
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
por: Zellinger, Barbara, et al.
Publicado: (2021) -
Hsa-miR-375 is a predictor of local control in early stage breast cancer
por: Zehentmayr, Franz, et al.
Publicado: (2016) -
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020) -
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022) -
Carbon Monoxide Diffusing Capacity (DL(CO)) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III
por: Stana, Markus, et al.
Publicado: (2022)